Study shows higher doses of once-daily oral semaglutide more effective in adults with type 2 diabetes
A study has demonstrated that the higher doses of oral semaglutide (25 mg and 50 mg) were more effective than the approved 14 mg dose in reducing HbA1c and bodyweight in adults with inadequately controlled type 2 diabetes. The safety profile of the higher doses did not raise any new concerns. This trial is registered with…